Hooper Holmes — Q3 2017 Earnings Presentation
8 slides from Hooper Holmes's earnings presentation, Nov 9, 2017
Slide 1: Q3 Earnings Results Presentation
(OTCQX: HPHW) Q3 Earnings Results Presentation Speakers: Henry Dubois, Chief Executive Officer Steven Balthazor, Chief Financial Officer Mark Clermont, President November 9th, 2017 (OTCQX: HPHW)
Slide 2: Safe Harbor
Safe Harbor 2 Special Note Regarding Forward-Looking Statements This presentation contains forward-looking statements, as such term is defined in the Private Securities Litigation Reform Act of 1995, concerning the Company’s plans, objectives, goals, strategies, future events or performances, which
Slide 3: Highlights
3 Highlights Strong Channel Partner and End Customer Support Merger resonates with marketplace $ 14 million in annualized new sales on a run rate basis Busy Season driving results Q3 Revenue: $ 14.0 million Q3 EBITDA: ($ 1.5 million) included duplicate operational costs that will be eliminat
Slide 4: Q3 Results
4 Q3 Results Strong Q3 revenues of $ 14.0 million 44% revenue improvement compared to Q3 2016 24% gross profit improvement compared to Q3 2016 Revenue ($mm) Gross Profit ($mm) +24% +44%
Slide 5: Synergies
5 Synergies Implementation of Synergies Synergy projects ahead of schedule Target: $ 7.0 million in annualized synergies $ 7.1 million already achieved Potential for additional savings based on initiatives in progress $ 7.1 million Annualized Synergy Savings already achieved $ 7.1 mm $ 7.0 m
Slide 6: Market and Competitive Landscape
Market and Competitive Landscape Employers Channel Partners $1.8b $7.4b Total Addressable Market Buyers 20% Mid-size private businesses 40% Large corp. Clinical Research 17% Public sector 13% Small business 10% Nonprofit ► Bio/Pharma ► Research Universities, e.g.: › University of Michigan › Add Heal
Slide 7: New Annualized Sales
7 New Annualized Sales Key New Direct Customers • Hospital chains (2) • National assisted living facility company • Big 4 accounting firm • National retail consumer product brand New Clinical Research Project • UNC longitudinal health study $ 11.9 $ 14.1
Slide 8: Conclusions and Outlook
8 Conclusions and Outlook • On track to deliver record number of screenings / flu shots • Exceeded forecasted synergy savings • Integration moving forward and progressing per plan 2017 Outlook • Solid customer base and revenue growth • Increased operating capabilities • Leverageable cost structure R